PATENT CLAIM ANALYSIS

Application Number: 16379169
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "329000"]

Abstract:
A method for treating a disease or disorder in a patient who is currently taking a cytochrome P450 inhibitor comprising administering to the patient a dose of pimavanserin or a pharmaceutical acceptable salt thereof, wherein the dose is at least 20% lower than a dose of pimavanserin or a pharmaceutical acceptable salt thereof that would otherwise have been recommended to the patient if the patient were not currently taking the cytochrome P450 inhibitor.

Claim (Index 1):
A method of treating psychosis secondary to neurodegenerative disorders in a patient in need thereof, wherein the patient is being treated concurrently with a strong CYP3A4 inhibitor, comprising orally administering to the patient 10 mg of pimavanserin once daily.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.65217
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12784738', '12867845', '14565039', '14614133', '13271830']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7517368952648718
- 35 USC 102 Novelty (BERT): 0.5013117373843466
- Combined Prediction Score: 0.7266943794768193
- Mean Citation Score: 203.973388
- Max Citation Score: 220.45349
- Similarity Product: 141.01186317649243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test